The American Diabetes Association (ADA)“Standards of Care in Diabetes” includes the
ADA's current clinical practice recommendations and is intended to provide the components …

Background The global burden of non-alcoholic fatty liver disease (NAFLD) parallels the
increase in obesity rates across the world. Although overweight and obesity status are …

Abbreviations: AASLD, American Association for the Study of Liver Diseases; AI, artificial
intelligence; ALT, alanine aminotransferase; AST, aspartate aminotransferase; AUROC …

Objective The objective of this clinical practice guideline is to provide updated and new
evidence-based recommendations for the comprehensive care of persons with diabetes …

Methods Prevalence data from 245 articles involving 2,699,627 persons were used with a
hierarchical Bayesian approach to forecast the prevalence of NAFLD through 2040 …

Background The prevalence of nonalcoholic fatty liver disease (NAFLD) is increasing. We
aimed to estimate the pooled global NAFLD incidence. Methods We performed a systematic …

Nonalcoholic fatty liver disease (NAFLD) is a dynamic chronic liver disease that develops in
close association with metabolic irregularities. Between 2016 and 2019, the global …

Given the tremendous potential and influence of artificial intelligence (AI) and algorithmic
decision‐making (DM), these systems have found wide‐ranging applications across diverse …

Nonalcoholic fatty liver disease (NAFLD) consists of a spectrum starting from NAFLD that
may progress to, nonalcoholic steatohepatitis (NASH) which can lead to fibrosis, cirrhosis …

OBJECTIVE Most people with type 2 diabetes (T2DM) and nonalcoholic steatohepatitis
(NASH) or advanced fibrosis (AF) remain undiagnosed, resulting in missed opportunities for …